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Critical care decision-support tools can focus on diagnostic
[1], administrative [2], or therapeutic needs. Decision-support
tools have been functionally categorized as ‘reminders,’ ‘con-
sultants,’ or ‘educational’ [3]. These three categories do not
embrace the intensive care unit (ICU) treatment management
or titration protocols used to apply explicit methods of
mechanical ventilation [4–6] and fluid and hemodynamic
support [7,8] in patients with acute lung injury or acute respi-
ratory distress syndrome (ARDS). In this review I focus on
these management or titration protocols and consider several
rationales for the use of such explicit detailed computerized
protocols in the ICU. I discuss the features of computerized
ICU protocols that distinguish them from other decision-
support tools such as guidelines, paper protocols, and clini-
cal or nursing or critical paths. These protocols complement,
but do not replace, the ICU decision-maker.
Varieties of decision-support tools
Thousands of decision-support tools with different names,
foci, and outputs are available but they often lack specific
instructions for many of the situations encountered in clinical
practice [9]. Most are useful only in a conceptual sense
[10–16]. They neither standardize clinical decisions nor lead
to a uniform implementation of clinical interventions, although
standardization and uniformity are their goals [14,16,17]. For
example, it would be difficult to reduce variability with a proto-
col that required the clinician to determine whether the
patient ‘looked septic,’ unless the state ‘looked septic’ were
explicitly defined. Computerized protocols used for complex
clinical problems can contain much more detail than is possi-
ble with textual guidelines or with paper-based flow diagrams
[16]. The increased detail allows the generation, at the point
of care, of patient-specific therapy instructions that can be
performed by different clinicians with almost no inter-clinician
variability [18]. This can make both formal clinical inquiries
(for example, randomized trials) and informal clinical inquiries
(for example, some continuous quality improvement efforts, or
clinical practice evaluations) more robust [9,18].
Reducing clinician variability might seem to challenge the
importance that clinicians assign to individualized (patient-
specific) therapy. Unexpectedly, individualization of patient
therapy is preserved when clinical decisions are standardized
with explicit, detailed, patient-data-driven, computerized pro-
tocols [9,19]. An essential element in achieving this unex-
pected result is the use of patient data (that is, the patient’s
unique expression of the disease) to drive the decision-
support tool (protocol) rules. Unlike these specific patient-
Review
Rational use of computerized protocols in the intensive care unit
Alan H Morris
LDS Hospital and University of Utah School of Medicine, Salt Lake City, USA
Correspondence: Alan H Morris, MD, ldamorri@ihc.com
Published online: 13 September 2001
Critical Care 2001, 5:249-254
© 2001 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X)
Abstract
Excess information in complex ICU environments exceeds human decision making limits, increasing the
likelihood of clinical errors. Explicit decision-support tools have favorable effects on clinician and
patient outcomes and can reduce the variation in clinical practice that persists even when guidelines
based on reputable evidence are available. Computerized protocols used for complex clinical problems
generate, at the point-of-care, patient-specific evidence-based therapy instructions that can be carried
out by different clinicians with almost no inter-clinician variability. Individualization of patient therapy is
preserved by these explicit protocols since they are driven by patient data. Computerized protocols
that aid ICU decision-makers should be more widely distributed.
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data-driven explicit methods [4,5,20–25], time-driven deci-
sion-support tools (for example a clinical path that requires
discharge of the patient after 3 days of care) raise legitimate
concerns about patient-invariant (‘cookbook’) care. Individual-
izing patient care while standardizing clinical decisions with
an explicit method is, in my opinion, one of the most attractive
attributes of the point-of-care use of computerized protocols.
Why is there need for protocols in the ICU?
Clinical error rates are common (about 1–50%) [26–53]. This
is an expression of the general problem: that human error and
injury are unavoidable [27,35,54,55]. Even when ICU errors
represent only 1% of clinical decisions [53] and therefore indi-
cate little room for personal improvement (in that 99% of deci-
sions are correct), clinical ICU errors and injuries that threaten
patient safety occur with distressing frequency [44,53].
Variation in clinical practice persists even when guidelines
based on reputable evidence are available [28,29], and
patients can be harmed when clinicians do not comply with
standard practice [9,30,31]. Widespread distribution of evi-
dence-based guidelines [35,36] and education programs
[24,37–40] has had only a limited effect on low compliance
by clinicians. Variability is fostered by incorrect perceptions.
The perceptions of physicians in their use of physiological
data and the actual use of such data in decision-making for
cardiac problems in the ICU are internally inconsistent
(within-decision-maker inconsistency) [56]. This is in part due
to the use of ill-defined terms or statements such as
‘…caution should be exercised when PAOP [pulmonary
artery occlusion pressure] becomes increased to the extent
that pulmonary edema is a risk’ [57]. This particular inconsis-
tency appeared in a journal issue containing three articles
that presented mutually contradictory sets of recommenda-
tions about hemodynamic monitoring (between-decision-
maker inconsistency) [58].
Variation in practices with ICU fluids and electrolytes illus-
trates the confusion propagated by the imprecise use of
words and concepts in medicine. An analytical scheme
addressing three major factors in fluid and electrolyte evalua-
tion (1, effectiveness of the arterial circulation; 2, extracellular
fluid volume [ECF]; and 3, state of hydration [59]) is compati-
ble with widely taught precepts [60–67]. Evaluating these
three concepts separately is important for clarifying problems
with fluids and electrolytes and thereby for reducing unneces-
sary variation. Use of fluid and electrolyte terms in a nonstan-
dardized manner leads to confusion. An American Medical
Association Council report cites isotonic, hypertonic, and
hypotonic dehydration, thereby confusing the evaluation of
the state of the ECF and the state of hydration [68]. Cardio-
vascular evaluation is also (inappropriately) included in the
evaluation of hydration, thereby confusing the evaluation of
the effectiveness of the arterial circulation (cardiovascular
evaluation) with the evaluation of the state of hydration.
Hypernatremic dehydration (a tautology if standard definitions
are used) was used to describe both dehydration (hyperna-
tremia) and ECF contraction [69]. For patients with traumatic
brain injury, dehydration was used in two contradictory ways
[70]. First, the authors recommended inducing dehydration
with mannitol (producing dehydration or underhydration
according to the standard terminology) because it was
effective in reducing intracranial pressure. They then recom-
mended avoiding dehydration with diuretics (producing ECF
contraction due to negative fluid balance) because it was
ineffective in reducing intracranial pressure [70]. The use and
the teaching of terms in such contradictory ways probably
contribute to the uncertainty surrounding fluid and electrolyte
therapy for sepsis [71], shock [72–74] and ARDS [75]. Fluid
and electrolyte therapy is an important and uncontrolled co-
intervention that can influence patient outcome and obscure
the effects of therapeutic interventions in clinical trials.
Protocols enhance efficiency, safety, and
efficacy of care
Efficiency is the term assigned to the evaluation of resource
consumption for a clinical intervention accepted as part of
routine practice. At the individual patient level, standardization
enhances efficiency by making the clinical plan explicit to all
providers dealing with that patient. Nurses, therapist, and
physicians thereby achieve a level of uniformity of approach
and goals for the specific patient. This reduces within-patient
variability of decision-making. However, this does not reduce
unnecessary variation between patients and between physi-
cians. Standardized clinical decisions are important at several
levels within the healthcare delivery system.
Human decision-making limitations, perceptual inaccuracies,
and variation in the use and in the interpretation of important
clinical variables all make clinicians unable to consistently
generate therapeutic decisions that are coherent, that con-
sider all appropriate options, and that are based on the rele-
vant scientific evidence [27,34,35,43,44,46,76–79]. For
example, adverse drug events are common, costly, and
largely preventable causes of excess morbidity and mortality
in ICU patients [25,80–82]. Estimates of the annual national
cost of adverse drug events in the USA run as high as US
$79 billion to US $136 billion [25,83]. Unfortunately, adverse
drug events are generally undetected. Traditional screening
for in-hospital adverse drug events detects only 1% and vol-
untary reporting only 12% of the adverse drug events
detected by automated computerized screening of an inte-
grated electronic clinical database [84].
Even when the healthcare community understands the proper
approach, compliance of physicians with evidence-based
treatments or guidelines is low across a broad range of
healthcare topics [20,85–89]. Patient [90] and hospital [91]
compliance is approximately as low. Only about 50% of
patients with chronic diseases receive effective delivery of
their therapy [90]. Like low compliance by clinicians, this































both paper-based and computerized decision-support tools
that provide explicit, point-of-care (point-of-decision-making)
instructions to clinicians have overcome many problems and
have achieved clinician compliance rates of 90–95%
[5,19,92]. However, the absence of requisite infrastructure in
the ICU environment is an important obstacle to the adoption
of clinical decision-support tools such as those demonstrated
to produce a favorable clinical outcome in a multicenter ran-
domized clinical trial [5,6].
Protocols enable rigorous clinical research
Modern medicine has fostered the development of undoubted
advances. In spite of these and other obvious benefits, only a
small fraction of current clinical practice has been shown to
produce more good than harm [18,32–34]. Some important
problems in critical care have long resisted resolution. While
our understanding of underlying mechanisms of injury and
inflammation in sepsis and ARDS has blossomed, our under-
standing of clinical management of sepsis and ARDS has not.
Several clinical trials of promising therapeutic agents have
consistently failed to identify the promised advances in therapy
[21,93–98]. The absence of a clear benefit from this broad
spectrum of tested interventions suggests that the clinical
problems are insoluble and cannot be improved, or that the
needed interventions have not yet been tested, or that our clin-
ical investigative strategy is not sound. We have all been
encouraged by recent advances in the treatment of patients
needing mechanical ventilation [92] and those with sepsis
[99], but our success rate with clinical trials that produce
important clinical advances is disappointingly low.
Standardization of clinical decisions is needed not only for
clinical practice but also for rigorous clinical research [49].
Many interventions of clinical value have relatively small
effects, with odds ratios of 3.0 or less [50]. Systematically
conducted clinical trials are necessary for these small effects
to be recognized and for ineffective clinical care elements to
be identified [50,51]. However, without explicit methods the
fundamental scientific requirement of replicability of results
[48,49] cannot be achieved. An explicit method, driven by
patient data, contains enough detail to generate specific
instructions (patient-specific orders) without requiring judg-
ments by a clinician. Any form of guideline or protocol can
theoretically contain enough detail to constitute an explicit
method. In practice, however, paper-based versions of any
protocols except the simplest (for example, vaccination
schedules or treatment of hypokalemia in a patient receiving
digitalis and diuretics) cannot be made explicit and therefore
remain dependent on the judgment of a clinician.
Protocols enhance education
If explicit computerized protocols lead clinical trainees to
abandon critical thinking, they might contribute to the produc-
tion of clinicians less prepared for the rigorous intellectual
challenge of healthcare delivery. For those afraid of demean-
ing the clinical training of students and house officers, I
respond that an explicit method, when used wisely, can be an
effective tool for teaching students the principles both of
decision-making and of clinical practice. Unlike much tradi-
tional clinical teaching, explicit decision-support tools articu-
late both the variables considered and the decision rules. In
an environment dedicated to training, explicit methods can be
an asset. In an environment that pays little heed to training,
they could be a disadvantage. Like any tool, guidelines can
be misused. Finally, many physicians are concerned about a
reduction of their role in medical practice and of the potential
disenchantment of physicians with medicine that could follow
the widespread mandatory use of guidelines and protocols
[15]. Standardization might be perceived as an attack on clin-
icians’ assumption that they possess special and ineffable
wisdom in clinical matters and on its corollary that patients
receive the best outcome when physicians independently use
their best clinical judgment [100,101]. It is this belief, namely
that expert ICU physicians possess special and ineffable
wisdom, that interferes with the education of young physi-
cians, by avoiding the challenge of articulating precisely how
decisions should be made.
Summary
The excess information in complex ICU environments
exceeds human decision-making limits, increasing the likeli-
hood of clinical errors. Explicit decision-support tools have
favorable effects on the clinician and on patient outcomes.
They have been implemented in diverse clinical environments
and have been successfully transferred and used in geo-
graphically dispersed ICUs that were not involved in their
initial development. However, various human factors and the
paucity of distributed electronic clinical databases impede
the widespread distribution of clinical decision-support tools.
Notwithstanding these challenges, the documented benefit of
the application of decision-support tools in the ICU and the
rapid expansion of electronic ICU databases promise an
increasingly favorable environment for the development,
implementation, and use of computerized protocols to aid
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